Atria Investments’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$849K Buy
26,954
+17,106
+174% +$539K 0.01% 1151
2025
Q4
$290K Buy
+9,848
New +$274K ﹤0.01% 1756
2025
Q3
Sell
-8,895
Closed -$213K 2131
2025
Q2
$213K Sell
8,895
-1,973
-18% -$45.7K ﹤0.01% 1889
2025
Q1
$249K Sell
10,868
-2,461
-18% -$59.4K ﹤0.01% 1721
2024
Q4
$337K Sell
13,329
-2,381
-15% -$60.3K ﹤0.01% 1537
2024
Q3
$392K Sell
15,710
-2,097
-12% -$62.1K ﹤0.01% 1457
2024
Q2
$528K Buy
+17,807
New +$494K 0.01% 1270

Other funds holding RTO

Atria Investments's RTO Position: Q1 2026 in Review

Atria Investments increased its Rentokil (RTO) stake by 174% in Q1 2026, buying an estimated $539K and bringing the position to 26,954 shares worth $849K. The position accounts for 0.01% of the portfolio, ranked #1151.

Atria Investments first reported a position in RTO in Q2 2024 and has held it in 7 quarters since. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Atria Investments held 26,954 shares of Rentokil worth $849K as of Q1 2026.
  • Atria Investments bought 17,106 Rentokil shares in Q1 2026, an estimated $539K.
  • Rentokil made up 0.01% of Atria Investments's portfolio in Q1 2026, its #1151 holding.
  • Atria Investments first reported a position in Rentokil in Q2 2024 and has held it in 7 quarters since.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.